Sale!

PIGN Gene Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 1 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The PIGN Gene Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 1 NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the PIGN gene responsible for this rare genetic disorder. This advanced next-generation sequencing test detects genetic variations that cause multiple congenital anomalies, severe muscle weakness (hypotonia), and recurrent seizures in affected individuals. The test provides crucial diagnostic information for infants and children presenting with developmental delays, distinctive facial features, and neurological symptoms. With results available in 3-4 weeks using blood or extracted DNA samples, this test enables early intervention and personalized treatment strategies. The discounted price of $500 USD makes this essential genetic testing accessible to families across the United States.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

PIGN Gene Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 1 NGS Genetic DNA Test

Comprehensive Genetic Testing for Developmental Disorders

The PIGN Gene Multiple Congenital Anomalies-Hypotonia-Seizures Syndrome Type 1 NGS Genetic DNA Test represents a breakthrough in pediatric genetic diagnostics. This sophisticated test utilizes next-generation sequencing technology to identify mutations in the PIGN gene, which plays a critical role in glycosylphosphatidylinositol (GPI) anchor biosynthesis. Disruptions in this essential biological process can lead to severe developmental abnormalities affecting multiple organ systems.

What This Test Measures and Detects

This advanced genetic test specifically targets the PIGN gene located on chromosome 18, analyzing its complete coding sequence to identify pathogenic variants including:

  • Point mutations and single nucleotide variants
  • Small insertions and deletions
  • Copy number variations affecting the PIGN gene
  • Compound heterozygous mutations
  • Autosomal recessive inheritance patterns

The test provides comprehensive coverage of all exons and flanking intronic regions, ensuring high sensitivity for detecting clinically relevant variants associated with this rare neurodevelopmental disorder.

Who Should Consider This Test

This genetic test is recommended for infants and children presenting with the following clinical features:

  • Multiple congenital anomalies affecting various organ systems
  • Severe hypotonia (muscle weakness) present from birth
  • Recurrent seizures or epileptic encephalopathy
  • Developmental delays and intellectual disability
  • Distinctive facial dysmorphic features
  • Growth retardation and failure to thrive
  • Structural brain abnormalities detected on imaging
  • Family history of similar neurological conditions

Clinical Benefits of Genetic Testing

Obtaining a definitive genetic diagnosis through this test provides numerous clinical advantages:

  • Accurate Diagnosis: Confirms the specific genetic cause of symptoms, eliminating diagnostic uncertainty
  • Personalized Treatment: Enables targeted therapeutic interventions and management strategies
  • Prognostic Information: Provides insight into disease progression and expected outcomes
  • Family Planning: Offers crucial information for genetic counseling and reproductive decisions
  • Early Intervention: Facilitates timely implementation of supportive therapies and educational plans
  • Research Participation: Opens opportunities for clinical trials and emerging treatments

Understanding Your Test Results

Our comprehensive genetic counseling services help you interpret your test results effectively:

  • Positive Result: Identifies pathogenic mutations in the PIGN gene, confirming the diagnosis and enabling targeted management
  • Negative Result: No mutations detected in the PIGN gene, suggesting alternative genetic or non-genetic causes
  • Variant of Uncertain Significance: Identifies genetic changes with unclear clinical implications requiring further evaluation
  • Carrier Status: Determines if individuals carry one copy of a mutated gene without showing symptoms

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $500
Regular Price $700

Turnaround Time: 3 to 4 Weeks
Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card

Pre-Test Requirements

Before scheduling your test, please ensure you have:

  • Complete clinical history of the patient
  • Scheduled genetic counseling session to create a detailed family pedigree
  • Documentation of affected family members with similar symptoms
  • Recent clinical evaluations and diagnostic reports

Nationwide Testing Availability

We have conveniently located testing facilities across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our state-of-the-art laboratories ensure consistent, high-quality testing regardless of location.

Take the Next Step Toward Diagnosis

Don’t let diagnostic uncertainty delay appropriate care for your child. Our specialized pediatric genetics team is ready to help you navigate this complex genetic condition. Contact us today to schedule your genetic counseling session and testing appointment.

Call or WhatsApp: +1(267) 388-9828
Book Your Test Today for Comprehensive Genetic Answers

Early genetic diagnosis can make a significant difference in managing PIGN-related disorders and improving quality of life. Trust our expertise in pediatric dysmorphology and genetic testing to provide the answers your family deserves.